Background
Clinical trial of G-CSF to reduce a certain type of toxicity
in cancer chemotherapy
Early in trial, high rates of another toxicity noted
Ed Korn at NCI consulted re early stopping
Much later, Ed Korn invites panel to address this problem
as an unknown at the JSM